The first dispute (35-page / 1.3MB PDF) is between Amgen on the one hand and Sanofi and Regeneron on the other, concerning two products – Amgen’s evolocumab, sold under the brand name Repatha, and Sanofi’s and Regeneron’s alirocumab,…
The first dispute (35-page / 1.3MB PDF) is between Amgen on the one hand and Sanofi and Regeneron on the other, concerning two products – Amgen’s evolocumab, sold under the brand name Repatha, and Sanofi’s and Regeneron’s alirocumab,…